Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
Trial design and data reporting The primary objective of this open-label, first-in-human, phase 1, three-arm umbrella trial (ClinicalTrials.gov:…
Browsing Tag
Tumour immunology
1 post